Cargando…

Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis

The World Health Organization recommends pre-exposure prophylaxis (PrEP) for individuals at substantial risk of HIV infection. The aim of this analysis is to quantify the individual risk of HIV infection over time, using a large database of high-risk individuals (n = 5583). We used data from placebo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia-Cremades, Maria, Hendrix, Craig W., Jayachandran, Priya, Strydom, Natasha, Jarlsberg, Leah, Grant, Robert, Celum, Connie L., Martin, Michael, Baeten, Jared M., Marrazzo, Jeanne, Anderson, Peter, Choopanya, Kachit, Vanichseni, Suphak, Glidden, David V., Savic, Radojka M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504389/ https://www.ncbi.nlm.nih.gov/pubmed/36145549 http://dx.doi.org/10.3390/pharmaceutics14091801

Ejemplares similares

HIV pre-exposure prophylaxis and health and community systems in the Global South: Thailand case study
por: Colby, Donn, et al.
Publicado: (2015)

A Mechanistic In Vivo/Ex Vivo Pharmacokinetic‐Pharmacodynamic Model of Tenofovir for HIV Prevention
por: Jayachandran, Priya, et al.
Publicado: (2021)

Risk Behaviors and Risk Factors for HIV Infection among Participants in the Bangkok Tenofovir Study, an HIV Pre-Exposure Prophylaxis Trial among People Who Inject Drugs
por: Martin, Michael, et al.
Publicado: (2014)

HIV Incidence and Risk Behaviours of People Who Inject Drugs in Bangkok, 1995–2012
por: Martin, Michael, et al.
Publicado: (2019)

Assessment of Oral Fluid HIV Test Performance in an HIV Pre-Exposure Prophylaxis Trial in Bangkok, Thailand
por: Suntharasamai, Pravan, et al.
Publicado: (2015)

Enrollment Characteristics and Risk Behaviors of Injection Drug Users Participating in the Bangkok Tenofovir Study, Thailand
por: Martin, Michael, et al.
Publicado: (2011)

Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for Injecting Drug Users
por: Smith, Dawn K., et al.
Publicado: (2013)

Clinical Pharmacokinetics of Oral Sodium Selenite and Dosing Implications in the Treatment of Patients with Metastatic Cancer
por: Jayachandran, Priya, et al.
Publicado: (2021)

Recalibration of the Limiting Antigen Avidity EIA to Determine Mean Duration of Recent Infection in Divergent HIV-1 Subtypes
por: Duong, Yen T., et al.
Publicado: (2015)

HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention
por: Donnell, Deborah, et al.
Publicado: (2014)

Fatal HIV Encephalitis in HIV-Seronegative Patients
por: Martin, Troy M., et al.
Publicado: (2009)

Circumcision of Male Children for Reduction of Future Risk for HIV: Acceptability among HIV Serodiscordant Couples in Kampala, Uganda
por: Mugwanya, Kenneth K., et al.
Publicado: (2011)

Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples
por: Ngure, Kenneth, et al.
Publicado: (2017)

Risk Factors for HSV-2 Infection among Sexual Partners of HSV-2/HIV-1 Co-Infected Persons
por: Mujugira, Andrew, et al.
Publicado: (2011)

High Medication Adherence During Periconception Periods Among HIV-1–Uninfected Women Participating in a Clinical Trial of Antiretroviral Pre-exposure Prophylaxis
por: Matthews, Lynn T., et al.
Publicado: (2014)

Estimating the impact of universal antiretroviral therapy for HIV serodiscordant couples through home HIV testing: insights from mathematical models
por: Roberts, Sarah T, et al.
Publicado: (2016)

Estimating the Cost-Effectiveness of Pre-Exposure Prophylaxis to Reduce HIV-1 and HSV-2 Incidence in HIV-Serodiscordant Couples in South Africa
por: Jewell, Britta L., et al.
Publicado: (2015)

Perceptions of pregnancy occurring among HIV-serodiscordant couples in Kenya
por: Kimemia, Grace, et al.
Publicado: (2019)

Cutaneous histoplasmosis in a HIV seronegative patient
por: Pal, Nandita, et al.
Publicado: (2013)

Home HIV testing and counseling for reducing HIV incidence in a generalized epidemic setting: a mathematical modeling analysis
por: Ying, Roger, et al.
Publicado: (2016)

Closing the gaps in the HIV care continuum
por: Barnabas, Ruanne V., et al.
Publicado: (2017)

866. Adherence to F/TDF for PrEP in Dried Blood Spots and HIV Infection Rates: A Pooled Analysis of Global PrEP Studies
por: Liu, Albert, et al.
Publicado: (2021)

The Incremental Cost of Delivering PrEP as a Bridge to ART for HIV Serodiscordant Couples in Public HIV Care Clinics in Kenya
por: Irungu, Elizabeth M., et al.
Publicado: (2019)

Household-Based HIV Counseling and Testing as a Platform for Referral to HIV Care and Medical Male Circumcision in Uganda: A Pilot Evaluation
por: Tumwebaze, Henry, et al.
Publicado: (2012)

Frequency of False Positive Rapid HIV Serologic Tests in African Men and Women Receiving PrEP for HIV Prevention: Implications for Programmatic Roll-Out of Biomedical Interventions
por: Ndase, Patrick, et al.
Publicado: (2015)

HIV and COVID-19: Lessons From HIV and STI Harm Reduction Strategies
por: Gravett, Ronnie M., et al.
Publicado: (2021)

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults
por: Mpendo, Juliet, et al.
Publicado: (2015)

219. A Randomized, Double-Masked, Placebo-Controlled Phase IIB Trial of Azithromycin and Trimethoprim-Sulfamethoxazole as Bacterial STI Prophylaxis in Pregnant Women with HIV
por: Dionne, Jodie, et al.
Publicado: (2022)

Clinical presentation of abdominal tuberculosis in HIV seronegative adults
por: Bolukbas, Cengiz, et al.
Publicado: (2005)

An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women
por: Balkus, Jennifer E., et al.
Publicado: (2016)

Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk?()()()
por: Smith, Jennifer A., et al.
Publicado: (2017)

Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples
por: Nakku‐Joloba, Edith, et al.
Publicado: (2019)

The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion
por: Donnell, Deborah, et al.
Publicado: (2017)

Feasibility and acceptability of HIV self-testing among pre-exposure prophylaxis users in Kenya
por: Ngure, Kenneth, et al.
Publicado: (2017)

Outcomes of hysterectomy in HIV-seropositive women compared to seronegative women.
por: Franz, Jennifer, et al.
Publicado: (2005)

Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment
por: Weller, Stephen, et al.
Publicado: (2013)

Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions
por: Hallett, Timothy B, et al.
Publicado: (2010)

Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial
por: Brown, Elizabeth R, et al.
Publicado: (2020)

Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: Results of analyses from a multicenter randomized trial
por: de Bruyn, Guy, et al.
Publicado: (2012)

The Relationship between Cocaine Use and Human Papillomavirus Infections in HIV-Seropositive and HIV-Seronegative Women
por: Minkoff, Howard, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ot23n9prg9vk7720fea0gjbfh7